Mark Klinger

Mark Klinger

Company: Adaptive Biotechnologies

Job title: Vice President, Cellular Research & Innovation


Disease-Specific TCR Clusters Inform Novel Target Discovery & Therapeutics in Autoimmunity 11:10 am

Overview of Adaptive's immune medicine drug discovery platform to identify naturally occuring, antigen-specific T cell receptors (TCRs) Selection and characterization of antigen-specific TCR candidates to inform the development of immune-based therapies Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.